Based on the cell free nucleic acid analysis information of blood samples, the results of microbiome and metabolite analysis of stool and urine samples of pancreatic cancer and bile duct cancer patients, the clinical correlations of them with primary cancer are evaluated. And based on these information, biomarkers for diagnosis, treatment, and prognosis of pancreatic and bile duct cancer are explored.
Study Type
OBSERVATIONAL
Enrollment
150
cell free DNA in blood and urine, metabolite/microbiome in urine and stool
Seoul National University Hospital
Seoul, South Korea
RECRUITINGSang Hyub Lee
Seoul, South Korea
RECRUITINGcorrelation of genetic mutation
concordance of genetic mutation between tissue and blood of treatment-naive status
Time frame: the day of study enrollment or the day of tissue and blood acquisition
correlation of genetic mutation burden and prognosis
correlation of genetic mutation burden and prognosis
Time frame: the day of study enrollment and follow-up till end of the study
correlation of metabolic change in urine metabolite and prognosis
analysis of correlation of metabolic change in urine metabolite and prognosis
Time frame: the day of study enrollment and follow-up till end of the study
correlation of microbiome in stool and prognosis
analysis of correlation of microbiome in stool and prognosis
Time frame: the day of study enrollment and follow-up till end of the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.